Delivery Order SPE2DB25D3005-SPE2DB26FQBAV
- Not listed
- The Defense Logistics Agency awarded a $11,972.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors (2 ml units). This is a non-set-aside competitive award with an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $147,013.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors, with a completion date of September 17, 2025. This non-set-aside contract represents a competitive award to the major pharmaceutical distributor, which maintains its corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $32,178 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors, with an ultimate completion date of October 22, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency awarded a $35,898.66 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of October 30, 2025. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls under...
- The Defense Logistics Agency awarded a $105,802.94 delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors. This non-set-aside, firm fixed-price contract is expected to be completed by November 10, 2025, with performance centered at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a $6,624.92 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation, performing out of the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $9,084.36 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on August 4, 2025, with completion scheduled for August 5, 2025. This is a firm fixed price, non-set-aside contract for pharmaceutical delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran...
- The Defense Logistics Agency awarded a $73,368.18 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors, with an ultimate completion date of September 10, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a $4,505.02 delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation, with performance scheduled to conclude on September 30, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $14,595.53 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on October 30, 2025, with an ultimate completion date of October 31, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB26FQBAVDelivery Order
The Defense Logistics Agency awarded a $36,704.63 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors. This is a firm fixed-price, non-set-aside contract with a completion date of November 7, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999.99 million pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. The company has demonstrated its capability to meet federal procurement requirements through competitive awards across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. The DLA Troop Support Medical contract represents a cornerstone vehicle for delivering essential pharmaceutical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning AmerisourceBergen as a primary supplier within the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.7k | 11/6/25 |